Ide T - Search Results

1

Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection.

Tanaka Y, Yeo AE, Orito E, Ito K, Hirashima N, Ide T, Sata M, Mizokami M. Tanaka Y, et al. Among authors: ide t. J Gastroenterol. 2004 Aug;39(8):769-75. doi: 10.1007/s00535-003-1387-1. J Gastroenterol. 2004. PMID: 15338371

2

Interferon-gamma brings additive anti-viral environment when combined with interferon-alpha in patients with chronic hepatitis C.

Kumashiro R, Ide T, Sasaki M, Murashima S, Suzuki H, Hino T, Morita Y, Miyajima I, Ogata K, Tanaka E, Yoshida H, Tanikawa K, Sata M. Kumashiro R, et al. Among authors: ide t. Hepatol Res. 2002 Jan;22(1):20-26. doi: 10.1016/s1386-6346(01)00113-9. Hepatol Res. 2002. PMID: 11804830

3

Short term and two-step interferon therapy for chronic hepatitis C patients with low HCV RNA levels.

Ide T, Kumashiro R, Hino T, Murashima S, Ogata K, Koga Y, Sata M. Ide T, et al. Hepatol Res. 2002 Feb;22(2):145-151. doi: 10.1016/s1386-6346(01)00127-9. Hepatol Res. 2002. PMID: 11818254

4

Incidence of Sjögren's syndrome in Japanese patients with hepatitis C virus infection.

Nagao Y, Hanada S, Shishido S, Ide T, Kumashiro R, Ueno T, Sata M. Nagao Y, et al. Among authors: ide t. J Gastroenterol Hepatol. 2003 Mar;18(3):258-66. doi: 10.1046/j.1440-1746.2003.02982.x. J Gastroenterol Hepatol. 2003. PMID: 12603525 Review.

5

A pilot study of eicosapentaenoic acid therapy for ribavirin-related anemia in patients with chronic hepatitis C.

Ide T, Okamura T, Kumashiro R, Koga Y, Hino T, Hisamochi A, Ogata K, Tanaka K, Kuwahara R, Seki R, Sata M. Ide T, et al. Int J Mol Med. 2003 Jun;11(6):729-32. Int J Mol Med. 2003. PMID: 12736713

6

Predictive factors for remission and death in 73 patients with autoimmune hepatitis in Japan.

Hino T, Kumashiro R, Ide T, Koga Y, Ishii K, Tanaka E, Morita Y, Hisamochi A, Murashima S, Tanaka K, Ogata K, Kuwahara R, Sata M; Autoimmune Hepatitis Study Group. Hino T, et al. Among authors: ide t. Int J Mol Med. 2003 Jun;11(6):749-55. Int J Mol Med. 2003. PMID: 12736717

7

Severe alcoholic hepatitis successfully treated by leukocytapheresis: a case report.

Tsuji Y, Kumashiro R, Ishii K, Arinaga T, Sakamoto Y, Tanabe R, Ogata K, Koga Y, Ide T, Ono N, Tanaka E, Abe H, Sata M. Tsuji Y, et al. Among authors: ide t. Alcohol Clin Exp Res. 2003 Aug;27(8 Suppl):26S-31S. doi: 10.1097/01.ALC.0000078607.32247.9D. Alcohol Clin Exp Res. 2003. PMID: 12960503

8

A real-time quantitative polymerase chain reaction method for hepatitis B virus in patients with chronic hepatitis B treated with lamivudine.

Ide T, Kumashiro R, Koga Y, Tanaka E, Hino T, Hisamochi A, Murashima S, Ogata K, Tanaka K, Kuwahara R, Sata M. Ide T, et al. Am J Gastroenterol. 2003 Sep;98(9):2048-51. doi: 10.1111/j.1572-0241.2003.07643.x. Am J Gastroenterol. 2003. PMID: 14499786

9

Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy.

Kuwahara R, Kumashiro R, Murashima S, Ogata K, Tanaka K, Hisamochi A, Hino T, Ide T, Tanaka E, Koga Y, Sata M. Kuwahara R, et al. Among authors: ide t. J Med Virol. 2004 Jan;72(1):26-34. doi: 10.1002/jmv.10558. J Med Virol. 2004. PMID: 14635007

10

Subclones of drug-resistant hepatitis B virus mutants and the outcome of breakthrough hepatitis in patients treated with lamivudine.

Kumashiro R, Kuwahara R, Ide T, Koga Y, Arinaga T, Hisamochi A, Ogata K, Tanaka K, Sata M. Kumashiro R, et al. Among authors: ide t. Intervirology. 2003;46(6):350-4. doi: 10.1159/000074991. Intervirology. 2003. PMID: 14688451

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,318 results

Search Page

Filters